Indefinite-Lived Research and Development Assets
Phillips 66 Indefinite-Lived Research and Development Assets decreased by 13.9% to $527.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 13.9%, from $612.00M to $527.00M. Over 5 years (FY 2020 to FY 2025), Indefinite-Lived Research and Development Assets shows a downward trend with a -6.2% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase indicates aggressive investment in external innovation, while a decrease may signal project completion, commercialization, or impairment charges.
Detailed definition
This represents the value of acquired in-process research and development (IPR&D) projects that have not yet reached com...
Peer comparison
Common in pharmaceutical and medical device sectors where M&A is a primary driver of R&D pipelines.
indefinite_lived_rd_assetsHistorical Data
| Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | Q4 '25 | |
|---|---|---|---|---|---|
| Value | $715.00M | $703.00M | $700.00M | $612.00M | $527.00M |
| QoQ Change | — | -1.7% | -0.4% | -12.6% | -13.9% |
| YoY Change | — | -1.7% | -0.4% | -12.6% | -13.9% |
Indefinite-Lived Research and Development Assets at Other Companies
Frequently Asked Questions
- What is Phillips 66's indefinite-lived research and development assets?
- Phillips 66 (PSX) reported indefinite-lived research and development assets of $527.00M in Q4 2025.
- How has Phillips 66's indefinite-lived research and development assets changed year-over-year?
- Phillips 66's indefinite-lived research and development assets decreased by 13.9% year-over-year, from $612.00M to $527.00M.
- What is the long-term trend for Phillips 66's indefinite-lived research and development assets?
- Over 5 years (2020 to 2025), Phillips 66's indefinite-lived research and development assets has grown at a -6.2% compound annual growth rate (CAGR), from $725.00M to $527.00M.
- What does indefinite-lived research and development assets mean?
- The value of ongoing research projects acquired from other companies that are not yet ready for sale.